AB Corporate Bond ETF (NASDAQ:EYEG) Short Interest Update

AB Corporate Bond ETF (NASDAQ:EYEG) was the target of a large decrease in short interest in June. As of June 15th, there was short interest totaling 100 shares, a decrease of 34.6% from the May 31st total of 153 shares. Based on an average daily volume of 142 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.0% of the company’s stock are short sold.

Institutional Investors Weigh In On AB Corporate Bond ETF

Several institutional investors have recently added to or reduced their stakes in EYEG. Kestra Advisory Services LLC bought a new position in AB Corporate Bond ETF during the 4th quarter worth about $34,000. Jane Street Group LLC raised its stake in shares of AB Corporate Bond ETF by 166.7% in the 4th quarter. Jane Street Group LLC now owns 15,741 shares of the specialty pharmaceutical company’s stock valued at $563,000 after purchasing an additional 9,839 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its holdings in shares of AB Corporate Bond ETF by 32.5% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 157,702 shares of the specialty pharmaceutical company’s stock valued at $5,634,000 after purchasing an additional 38,685 shares in the last quarter. 64.16% of the stock is owned by institutional investors.

AB Corporate Bond ETF Stock Performance

Shares of EYEG opened at $35.13 on Thursday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.07 and a current ratio of 3.07. AB Corporate Bond ETF has a twelve month low of $34.82 and a twelve month high of $36.63. The firm’s 50 day moving average price is $35.23 and its two-hundred day moving average price is $35.52. The firm has a market cap of $28.10 million, a P/E ratio of -20.91 and a beta of 0.17.

AB Corporate Bond ETF Cuts Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, July 7th. Investors of record on Wednesday, July 1st will be issued a dividend of $0.1358 per share. This represents a c) dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date is Wednesday, July 1st. AB Corporate Bond ETF’s dividend payout ratio (DPR) is presently -102.98%.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.